Table 3.
Characteristic | HEHE(n = 25 patients) | Hemangioma/FNH(n = 45 patients) |
Arterial phase | ||
Rim like hyperenhancement | 18 (72) | 0 |
Heterogeneously hyperenhancement | 7 (28) | 6 (13.3) |
Peripheral nodular enhancement | 0 | All hemangioma |
Central arterial blood supply | All FNH | |
Portal-venous phase | ||
Hyperenhancement | 0 | 100 (100.0%) |
Hypoenhancement | 25 (100) | 0 |
Isoenhancement | 0 | 0 |
Late phase | ||
Hyperenhancement | 0 | 45 (100.0%) |
Hypoenhancement | 25 (100) | 0 |
Isoenhancement | 0 | 0 |
Sensitivity | ||
Rim like hyperenhancement | 18/25 (72) | 0 |
Hypoenhancement at portal venous phase | 25/25 (100) | 0 |
Central unenhanced area at late phase | ||
Yes | 18 (72) | 13 (28.9) |
No | 7 (28) | 32 (71.1) |
CEUS: Contrast enhanced ultrasound; HEHE: Hepatic epithelioid haemangioendothelioma; FNH: Focal nodular hyperplasia.